Home › Funds › Spruce Street Capital LP › IPSC
Spruce Street Capital LP position in IPSC
Century Therapeutics, Inc. · Health Care
Spruce Street Capital LP reported holding 4,059,054 shares of IPSC (Century Therapeutics, Inc.) in its Q3 2026 13F filing — a position valued at US$6.9M, representing 1.10% of its reported portfolio and ranking #24 among its reported holdings. Spruce Street Capital LP has disclosed IPSC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Spruce Street Capital LP's IPSC position evolved
Spruce Street Capital LP first disclosed a stake in IPSC in Q4 2025 at 1,421,532 shares (US$1.4M). The position peaked in Q2 2026 at 4,059,054 shares, worth US$9.9M. Across 4 filings, Spruce Street Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 4,059,054 shares valued at US$6.9M. Notable position changes include a 186% increase in Q1 2026 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.42M | $1.41M | New |
| Q1 2026 | 4.06M | $9.17M | Add |
| Q2 2026 | 4.06M | $9.94M | Hold |
| Q3 2026 | 4.06M | $6.94M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IPSC and 13F data
IPSC (Century Therapeutics, Inc.) is a Health Care company. 48 other funds we track also report a position in IPSC — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$43.5M), TCG Crossover Management, LLC (US$43.4M), Commodore Capital LP (US$21.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IPSC
- RA CAPITAL MANAGEMENT, L.P. 17.75M sh · $43.50M · Q2 2026
- TCG Crossover Management, LLC 17.75M sh · $43.40M · Q2 2026
- Commodore Capital LP 8.70M sh · $21.30M · Q2 2026
- Venrock Adviser, LLC 8.70M sh · $21.30M · Q2 2026
- Versant Venture Management, LLC 12.17M sh · $20.80M · Q3 2026
- Seven Fleet Capital Management LP 4.35M sh · $10.65M · Q2 2026
- Trails Edge Capital Partners, LP 4.13M sh · $10.13M · Q2 2026
- DAFNA Capital Management LLC 2.40M sh · $5.88M · Q2 2026
- STEMPOINT CAPITAL LP 2.15M sh · $5.26M · Q2 2026
- DV Trading LLC 1.40M sh · $3.43M · Q2 2026
- Casdin Capital 1.23M sh · $3.01M · Q2 2026
More on Spruce Street Capital LP
FAQ
How long has Spruce Street Capital LP held IPSC?
Spruce Street Capital LP has disclosed IPSC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Spruce Street Capital LP's current position in IPSC?
As of Q3 2026, Spruce Street Capital LP holds 4.06M shares of IPSC (Century Therapeutics, Inc.), valued at $6.94M, representing 1.10% of its reported portfolio and ranking #24.
Has Spruce Street Capital LP been buying or selling IPSC?
In the latest 13F filing (Q3 2026), Spruce Street Capital LP held unchanged its position in IPSC. The position peaked in Q2 2026 at 4.06M shares.
Which other funds hold IPSC?
Other major institutional holders of IPSC include RA CAPITAL MANAGEMENT, L.P., TCG Crossover Management, LLC, Commodore Capital LP, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.